Code Snippets
curl "https://financialdata.net/api/v1/stock-prices?identifier=SYK&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/stock-prices?identifier=SYK&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/stock-prices?identifier=SYK&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "SYK",
"date": "2026-10-14",
"open": 285.66,
"high": 285.66,
"low": 278.575,
"close": 281.62,
"volume": 2228464.0
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security. (e.g., MSFT) |
| offset | integer | (Optional) The initial position of the record subset, which indicates how many records to skip. Defaults to 0. (e.g., 300) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
The API endpoint provides more than 10 years of daily historical stock prices and volumes. The data covers several thousand US and international companies. There is a limit of 300 records per API call.
Company Profile
STRYKER CORP
NYSE: SYK- Market Cap:$144.31B
- ISIN:US8636671013
- Fiscal Year End:12/31
- CEO:Kevin A. Lobo
- Employees:53000
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology (60% of 2024 revenues), which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery (40% of 2024 revenues), which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.